Immunology
-
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
This article has 11 authors:Reviewed by ScreenIT
-
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
This article has 15 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice
This article has 12 authors:Reviewed by ScreenIT
-
In silico analysis predicts a limited impact of SARS-CoV-2 variants on CD8 T cell recognition
This article has 3 authors:Reviewed by ScreenIT
-
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
This article has 32 authors:Reviewed by ScreenIT
-
A mRNA vaccine encoding for a RBD 60-mer nanoparticle elicits neutralizing antibodies and protective immunity against the SARS-CoV-2 delta variant in transgenic K18-hACE2 mice
This article has 15 authors:Reviewed by ScreenIT
-
Macrophages only sense infectious SARS-CoV-2 when they express sufficient ACE2 to permit viral entry, where rapid cytokine responses then limit viral replication
This article has 24 authors:Reviewed by ScreenIT
-
Humoral and cellular immune memory to four COVID-19 vaccines
This article has 18 authors:Reviewed by ScreenIT
-
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster
This article has 13 authors:Reviewed by ScreenIT
-
Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19
This article has 12 authors:Reviewed by ScreenIT